Depressive episodes, the most frequent episodes in bipolar disorder, contribute in large part
to poor functional outcomes. Very few treatments, however, have been approved by the …

Аннотация В обзоре представлен анализ данных современных научных публикаций,
посвященных практическим аспектам применения антипсихотика карипразина при …

Post hoc analyses evaluated cariprazine, a dopamine D 3-preferring D 3/D 2 receptor partial
agonist, in patients with bipolar I depression and high baseline anxiety. Data were pooled …

This issue of the Journal focuses on a series of important questions related to the diagnosis
and treatment of bipolar disorder, which are highly relevant to our routine clinical activity …

The treatment of mood disorders, and depression, in particular, is usually complex. A large
number of factors influence both clinical presentation and treatment outcomes (Nierenberg …

Аннотация Актуальность. Биполярное аффективное расстройство относится к
тяжелым хроническим психическим расстройствам, встречается со значительной …

Background Bipolar disorder type I is a severe psychiatric condition that leads to significant
morbidity and mortality and whose treatment remains suboptimal. Its pathophysiology …

Аннотация Биполярное аффективное расстройство (БАР) является серьезной
проблемой общественного здравоохранения, связанной со значительной …

Bipolar depression treatment is still a challenge for clinicians, despite recommendations
from guidelines (Yatha m et al., 2018; Malhi et al., 2020) and meta analyses (Bahji et al …

The treatment of schizophrenia has relied over the past 70 years on the reduction of
dopamine transmission via blockade of postsynaptic dopamine D2 receptors without or with …